SEC Form 4/A · accession 0001209191-17-004954
Corbus Pharmaceuticals Holdings, Inc. · CRBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Yuval Cohen
Officer — Chief Executive Officer · Director
Period of report
Nov 22, 2016
Accepted (ET)
Jan 20, 2017 · 5:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001595097
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 22, 2016 | P | 1,340 | $7.64 | A | 32,830 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This amendment is being filed solely for the purpose of correcting the number of securities reported in Box 5 to Table 1 to indicate the number of securities beneficially owned following the transaction.